Cargando…
Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503372/ https://www.ncbi.nlm.nih.gov/pubmed/31080577 http://dx.doi.org/10.1186/s13569-019-0117-2 |
_version_ | 1783416396988809216 |
---|---|
author | Call, Jerry W. Wang, Yu Montoya, Denisse Scherzer, Norman J. Heinrich, Michael C. |
author_facet | Call, Jerry W. Wang, Yu Montoya, Denisse Scherzer, Norman J. Heinrich, Michael C. |
author_sort | Call, Jerry W. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6503372 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-65033722019-05-10 Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry Call, Jerry W. Wang, Yu Montoya, Denisse Scherzer, Norman J. Heinrich, Michael C. Clin Sarcoma Res Correction BioMed Central 2019-05-07 /pmc/articles/PMC6503372/ /pubmed/31080577 http://dx.doi.org/10.1186/s13569-019-0117-2 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Correction Call, Jerry W. Wang, Yu Montoya, Denisse Scherzer, Norman J. Heinrich, Michael C. Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry |
title | Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry |
title_full | Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry |
title_fullStr | Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry |
title_full_unstemmed | Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry |
title_short | Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry |
title_sort | correction to: survival in advanced gist has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from life raft group registry |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503372/ https://www.ncbi.nlm.nih.gov/pubmed/31080577 http://dx.doi.org/10.1186/s13569-019-0117-2 |
work_keys_str_mv | AT calljerryw correctiontosurvivalinadvancedgisthasimprovedovertimeandcorrelateswithincreasedaccesstopostimatinibtyrosinekinaseinhibitorsresultsfromliferaftgroupregistry AT wangyu correctiontosurvivalinadvancedgisthasimprovedovertimeandcorrelateswithincreasedaccesstopostimatinibtyrosinekinaseinhibitorsresultsfromliferaftgroupregistry AT montoyadenisse correctiontosurvivalinadvancedgisthasimprovedovertimeandcorrelateswithincreasedaccesstopostimatinibtyrosinekinaseinhibitorsresultsfromliferaftgroupregistry AT scherzernormanj correctiontosurvivalinadvancedgisthasimprovedovertimeandcorrelateswithincreasedaccesstopostimatinibtyrosinekinaseinhibitorsresultsfromliferaftgroupregistry AT heinrichmichaelc correctiontosurvivalinadvancedgisthasimprovedovertimeandcorrelateswithincreasedaccesstopostimatinibtyrosinekinaseinhibitorsresultsfromliferaftgroupregistry |